Notable Upgrades: Texas Instruments (TXN), Apple Inc. (AAPL), SeaWorld (SEAS), Twitter (TWTR), Allscripts Healthcare (MDRX)

Analysts at Raymond James are out with a report this morning upgrading shares of Texas Instruments Inc. (TXN) with a ‘Strong Buy‘ from ‘Market Perform‘ rating. The firm set its price target for the company to $62.

Texas Instruments Inc. shares are currently priced at 20.19x this year’s forecasted earnings, compared to the industry’s 3.00x earnings multiple. Ticker has a forward P/E of 18.43 and t-12 price-to-sales ratio of 4.33. EPS for the same period is $2.75.

In the past 52 weeks, shares of Dallas, Texas-based company have traded between a low of $41.47 and a high of $59.99 and are now at $55.45. Shares are up 15.90% year-over-year and 3.00% year-to-date.

In a report published Monday, Brean Capital analysts initiated coverage on Apple Inc. (AAPL) with a ‘Buy‘ rating and $160 price target.

On valuation measures, Apple Inc. shares currently have a PEG and forward P/E ratio of 1.14 and 14.12, respectively. Price/sales for the same period is 3.80 while EPS is $7.39. Currently there are 32 analysts that rate AAPL a ‘Buy’, 14 rate it a ‘Hold’. 2 analysts rate it a ‘Sell’. AAPL has a median Wall Street price target of $145.00 with a high target of $185.00.

In the past 52 weeks, shares of Cupertino, California-based tech giant have traded between a low of $81.79 and a high of $133.60 and are now at $132.60. Shares are up 63.67% year-over-year and 18.49% year-to-date. Apple is scheduled to report its earnings results after today’s closing bell.

Analysts at Goldman Sachs (GS) upgraded their rating on the shares of SeaWorld Entertainment, Inc. (SEAS). In a research note published on Monday, the firm lifted the name with a ‘Buy‘ from ‘Neutral‘ rating and set a 12-month base case estimate of $26 from $18 per share.

SEAS shares recently gained $0.50 to $21.99. Goldman’s target price suggests a potential upside of about 18% from the company’s current stock price.

In the past 52 weeks, shares of Orlando, Florida-based company have traded between a low of $15.11 and a high of $31.46. Shares are down 26.28% year-over-year ; up 22.92% year-to-date.

Twitter, Inc. (TWTR) was reiterated a ‘Buy’ by Axiom Capital analysts on Monday. The broker also raised its price target on the stock to $63 from $60.

Twitter, Inc., currently valued at $33.98 billion, has a median Wall Street price target of $52.00 with a high target of $67.00. Approximately 17.28 million shares have already changed hands, compared to the stock’s average daily volume of 19.78 million.

In the past 52 weeks, shares of San Francisco, California-based global platform for public self-expression have traded between a low of $29.51 and a high of $55.99 with the 50-day MA and 200-day MA located at $49.74 and $44.16 levels, respectively. Additionally, shares of TWTR trade at a P/E ratio of 1.90 and have a Relative Strength Index (RSI) and MACD indicator of 56.85 and -0.17, respectively.

TWTR currently prints a one year return of about 14% and a year-to-date return of around 42%.

Allscripts Healthcare Solutions, Inc. (MDRX) was raised to ‘Neutral‘ from ‘Underweight‘ and it was given a $12 from $9 price target at Piper Jaffray on Monday.

MDRX is up $0.35 at $12.94 on heavy volume. Midway through trading Monday, 4.06 million shares of Allscripts Healthcare Solutions Inc. have exchanged hands as compared to its average daily volume of 2.30 million shares. The stock ranged in a price between $12.83-$13.02 after having opened the day at $12.90 as compared to the previous trading day’s close of $12.59.

In the past 52 weeks, shares of Chicago, Illinois-based company have traded between a low of $11.00 and a high of $17.17. Shares are down 20.01% year-over-year and 1.41% year-to-date.

Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!

Be the first to comment

Leave a Reply

Your email address will not be published.


*

This site uses Akismet to reduce spam. Learn how your comment data is processed.